Literature DB >> 16738306

Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity.

J Román Cabrero1, Juan M Serrador, Olga Barreiro, María Mittelbrunn, Salvador Naranjo-Suárez, Noa Martín-Cófreces, Miguel Vicente-Manzanares, Ralph Mazitschek, James E Bradner, Jesús Avila, Agustín Valenzuela-Fernández, Francisco Sánchez-Madrid.   

Abstract

In this work, the role of HDAC6, a type II histone deacetylase with tubulin deacetylase activity, in lymphocyte polarity, motility, and transmigration was explored. HDAC6 was localized at dynamic subcellular structures as leading lamellipodia and the uropod in migrating T-cells. However, HDAC6 activity did not appear to be involved in the polarity of migrating lymphocytes. Overexpression of HDAC6 in freshly isolated lymphocytes and T-cell lines increased the lymphocyte migration mediated by chemokines and their transendothelial migration under shear flow. Accordingly, the knockdown of HDAC6 expression in T-cells diminished their chemotactic capability. Additional experiments with HDAC6 inhibitors (trichostatin, tubacin), other structural related molecules (niltubacin, MAZ-1391), and HDAC6 dead mutants showed that the deacetylase activity of HDAC6 was not involved in the modulatory effect of this molecule on cell migration. Our results indicate that HDAC6 has an important role in the chemotaxis of T-lymphocytes, which is independent of its tubulin deacetylase activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16738306      PMCID: PMC1525231          DOI: 10.1091/mbc.e06-01-0008

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  54 in total

Review 1.  T-cell function and migration. Two sides of the same coin.

Authors:  U H von Andrian; C R Mackay
Journal:  N Engl J Med       Date:  2000-10-05       Impact factor: 91.245

Review 2.  Cellular motility driven by assembly and disassembly of actin filaments.

Authors:  Thomas D Pollard; Gary G Borisy
Journal:  Cell       Date:  2003-02-21       Impact factor: 41.582

Review 3.  Cell migration: integrating signals from front to back.

Authors:  Anne J Ridley; Martin A Schwartz; Keith Burridge; Richard A Firtel; Mark H Ginsberg; Gary Borisy; J Thomas Parsons; Alan Rick Horwitz
Journal:  Science       Date:  2003-12-05       Impact factor: 47.728

4.  The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress.

Authors:  Yoshiharu Kawaguchi; Jeffrey J Kovacs; Adam McLaurin; Jeffery M Vance; Akihiro Ito; Tso Pang Yao
Journal:  Cell       Date:  2003-12-12       Impact factor: 41.582

5.  HDAC6 deacetylase activity links the tubulin cytoskeleton with immune synapse organization.

Authors:  Juan M Serrador; Jose Román Cabrero; David Sancho; María Mittelbrunn; Ana Urzainqui; Francisco Sánchez-Madrid
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

Review 6.  Role of the cytoskeleton during leukocyte responses.

Authors:  Miguel Vicente-Manzanares; Francisco Sánchez-Madrid
Journal:  Nat Rev Immunol       Date:  2004-02       Impact factor: 53.106

7.  Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation.

Authors:  Stephen J Haggarty; Kathryn M Koeller; Jason C Wong; Christina M Grozinger; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-03       Impact factor: 11.205

8.  Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases.

Authors:  Matthew H Brush; Amaris Guardiola; John H Connor; Tso-Pang Yao; Shirish Shenolikar
Journal:  J Biol Chem       Date:  2003-12-10       Impact factor: 5.157

9.  Localized stabilization of microtubules by integrin- and FAK-facilitated Rho signaling.

Authors:  Alexander F Palazzo; Christina H Eng; David D Schlaepfer; Eugene E Marcantonio; Gregg G Gundersen
Journal:  Science       Date:  2004-02-06       Impact factor: 47.728

10.  Toward an HDAC6 inhibitor: synthesis and conformational analysis of cyclic hexapeptide hydroxamic acid designed from alpha-tubulin sequence.

Authors:  Binoy Jose; Shinji Okamura; Tamaki Kato; Norikazu Nishino; Yuko Sumida; Minoru Yoshida
Journal:  Bioorg Med Chem       Date:  2004-03-15       Impact factor: 3.641

View more
  34 in total

1.  An Integrated Genetic-Genomic Approach for the Identification of Novel Cancer Loci in Mice Sensitized to c-Myc-Induced Apoptosis.

Authors:  Susan M Mendrysa; Keiko Akagi; Jean Roayaei; Wen-Hui Lien; Neal G Copeland; Nancy A Jenkins; Robert N Eisenman
Journal:  Genes Cancer       Date:  2010-05

Review 2.  Bringing up the rear: defining the roles of the uropod.

Authors:  Francisco Sánchez-Madrid; Juan M Serrador
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04-17       Impact factor: 94.444

3.  Fluorous-based small-molecule microarrays for the discovery of histone deacetylase inhibitors.

Authors:  Arturo J Vegas; James E Bradner; Weiping Tang; Olivia M McPherson; Edward F Greenberg; Angela N Koehler; Stuart L Schreiber
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

4.  Differential distribution of posttranslationally modified microtubules in osteoclasts.

Authors:  Toshitaka Akisaka; Hisaho Yoshida; Toshiya Takigawa
Journal:  J Histochem Cytochem       Date:  2011-03-18       Impact factor: 2.479

5.  Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin.

Authors:  David Kaluza; Jens Kroll; Sabine Gesierich; Tso-Pang Yao; Reinier A Boon; Eduard Hergenreider; Marc Tjwa; Lothar Rössig; Edward Seto; Hellmut G Augustin; Andreas M Zeiher; Stefanie Dimmeler; Carmen Urbich
Journal:  EMBO J       Date:  2011-08-16       Impact factor: 11.598

Review 6.  Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.

Authors:  Katrina J Falkenberg; Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2014-08-18       Impact factor: 84.694

7.  Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report.

Authors:  David Ritchie; Richard L Piekarz; Piers Blombery; Laszlo J Karai; Stefania Pittaluga; Elaine S Jaffe; Mark Raffeld; John E Janik; H Miles Prince; Susan E Bates
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

8.  The interplay between G protein-coupled receptor kinase 2 (GRK2) and histone deacetylase 6 (HDAC6) at the crossroads of epithelial cell motility.

Authors:  Vanesa Lafarga; Federico Mayor; Petronila Penela
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

9.  Identification of HDAC6-Selective Inhibitors of Low Cancer Cell Cytotoxicity.

Authors:  Irina N Gaisina; Werner Tueckmantel; Andrey Ugolkov; Sida Shen; Jessica Hoffen; Oleksii Dubrovskyi; Andrew Mazar; Renee A Schoon; Daniel Billadeau; Alan P Kozikowski
Journal:  ChemMedChem       Date:  2015-11-23       Impact factor: 3.466

10.  CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin.

Authors:  Sara A Wickström; Katarzyna C Masoumi; Saadi Khochbin; Reinhard Fässler; Ramin Massoumi
Journal:  EMBO J       Date:  2009-11-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.